Corcept Therapeutics Incorporated (CORT) Gains on FDA Approval, But Questions Remain

10 hours ago 1

Corcept Therapeutics Incorporated (NASDAQ:CORT) is among the 5 Best Stocks to Buy for Short Term. On March 25, Wolfe Research upgraded Corcept Therapeutics Incorporated (NASDAQ:CORT) to Peerperform from Underperform pursuing the FDA support for relacorilant. The steadfast believes this support volition region a large downside hazard for the stock, adding that the sustainability of the company’s halfway Cushing’s syndrome franchise remains unclear.

On the aforesaid day, Corcept Therapeutics Incorporated (NASDAQ:CORT) announced that the U.S. Food and Drug Administration approved Lifyorli (relacorilant) successful operation with nab-paclitaxel arsenic a solution for patients with platinum-resistant epithelial ovarian, fallopian tube, oregon superior peritoneal cancer. This cause marks the archetypal FDA-approved selective glucocorticoid receptor antagonist.

ADMA Biologics (ADMA) Announces $200M Capital Return Program Including $125M ASR Agreement

The proceedings achieved its dual superior endpoints, with patients treated with Lifyorli positive nab-paclitaxel witnessing a 35% simplification successful the hazard of decease comparative to patients treated with nab-paclitaxel alone. Additionally, patients saw a 30% little hazard of illness progression.

Overall, Corcept Therapeutics Incorporated (NASDAQ:CORT) has a Buy standing from 71% of the analysts covering the stock, with the remaining 29% holding a cautious view. The 1-year median terms people of $60 reflects an upside imaginable of 59.19%.

Corcept Therapeutics Incorporated (NASDAQ:CORT), incorporated successful 1998, is simply a California-based biopharmaceutical institution that discovers and develops solutions for superior endocrinologic, oncologic, metabolic, and neurologic disorders.

While we admit the imaginable of CORT arsenic an investment, we judge definite AI stocks connection greater upside imaginable and transportation little downside risk. If you're looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the best short-term AI stock.

READ NEXT: 33 Stocks That Should Double successful 3 Years and 15 Stocks That Will Make You Rich successful 10 Years

Disclosure: None. Follow Insider Monkey connected Google News.

Read Entire Article